"The U.S. market for companion animal medications (“pet medications”) has grown significantly
in the last decade. This growth is reflected in increased sales of both prescription and nonprescription
(also referred to as “over-the-counter” or “OTC”) medications. Recognizing the
economic importance of the pet medications industry for American consumers, and in response
to legislative proposals regarding prescriptions for pet medications, the Federal Trade
Commission’s (“FTC” or “Commission”) staff compiled information concerning historic and
current business practices in the sale of pet medications. Staff primarily focused on two related
issues that directly affect consumers’ access to competitively priced pet medications:
• the availability of “portable” pet medication prescriptions, obtained from
veterinarians and used to purchase prescription pet medications somewhere other than
the prescribing veterinarian’s office; and
• manufacturer distribution policies and practices for both prescription and OTC
pet medications..."
Pet Medication
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment